Stocky
MRK
Merck & Co., Inc.
NYSE · Healthcare · US
128.32
▲ +0.25%

What's happening at Merck & Co., Inc.

Merck & Co., Inc.'s latest moves, explained simply — so you know why the numbers change.

Straight from SEC filings · updated 6 Aug 2026
Big update 4 Aug 2026

Reports second quarter 2026 earnings results

Quarterly earnings show how much profit Merck made and help investors track business performance.

SEC 8-K · filed 2026-08-04 View filing ↗
Governance 28 May 2026

Shareholders elect thirteen directors to board

Board members make major company decisions; shareholders voting on them ensures investor democracy.

SEC 8-K · filed 2026-05-28 View filing ↗
Money 22 May 2026

Closes five billion dollar debt offering in May

Borrowing money affects company finances; investors need to know debt levels and repayment plans.

SEC 8-K · filed 2026-05-22 View filing ↗
Money 20 May 2026

Prepares five billion dollar debt offering

Company filing documents for large loan shows financing plans affecting future financial health.

SEC 424B5 · filed 2026-05-20 View filing ↗
Money 18 May 2026

Prepares five billion dollar debt offering

Company filing documents for large loan shows financing plans affecting future financial health.

SEC 424B5 · filed 2026-05-18 View filing ↗
Earnings 4 May 2026

Files first quarter 2026 financial results

Quarterly reports show detailed financial data helping investors understand company operations and progress.

SEC 10-Q · filed 2026-05-04 View filing ↗
Earnings 30 Apr 2026

Reports first quarter 2026 earnings results

Quarterly earnings show how much profit Merck made and help investors track business performance.

SEC 8-K · filed 2026-04-30 View filing ↗

Common questions

How does Stocky track Merck & Co., Inc.'s company events?

Stocky reads Merck & Co., Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.

What was Merck & Co., Inc.'s most recent SEC filing?

Merck & Co., Inc.'s most recent tracked filing was a 8-K on 4 Aug 2026: Reports second quarter 2026 earnings results.

Is this financial advice?

No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.

See Merck & Co., Inc.'s full breakdown on Stocky →

Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.